Vimian Group AB (publ) (VIMGF)
- Previous Close
4.0000 - Open
4.0000 - Bid 3.6600 x 40000
- Ask 4.6600 x 40000
- Day's Range
4.0000 - 4.0000 - 52 Week Range
2.2500 - 4.1200 - Volume
100 - Avg. Volume
884 - Market Cap (intraday)
2.228B - Beta (5Y Monthly) 1.62
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings Date Oct 24, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the Indical Bioscience brand name. It also provides procurement and tech-driven operations, such as online marketing, and education and HR, as well as a community for veterinary clinics through a membership-based platform under the VetFamily brand name; and orthopedic implants for veterinarians and universities under the Movora brand name. Vimian Group AB (publ) was incorporated in 2020 and is headquartered in Stockholm, Sweden.
vimian.com1,100
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: VIMGF
View MorePerformance Overview: VIMGF
Trailing total returns as of 10/30/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: VIMGF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: VIMGF
View MoreValuation Measures
Market Cap
2.23B
Enterprise Value
2.46B
Trailing P/E
191.28
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.59
Price/Book (mrq)
2.59
Enterprise Value/Revenue
6.45
Enterprise Value/EBITDA
32.40
Financial Highlights
Profitability and Income Statement
Profit Margin
0.07%
Return on Assets (ttm)
2.51%
Return on Equity (ttm)
0.16%
Revenue (ttm)
352.39M
Net Income Avi to Common (ttm)
256k
Diluted EPS (ttm)
-0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
39.17M
Total Debt/Equity (mrq)
37.62%
Levered Free Cash Flow (ttm)
-49.33M
Company Insights: VIMGF
VIMGF does not have Company Insights